Skip to main content
. 2020 Jan 7;2020:5146765. doi: 10.1155/2020/5146765

Table 2.

Clinical characteristics of participants at baseline (n = 418).

Variables All patients Adherence group Nonadherence group P value
FEV1 (L) 1.12 ± 0.39 1.13 ± 0.35 1.11 ± 0.42 0.072
FEV1% 48.9 ± 12.4 48.3 ± 12 49.7 ± 13 0.243
FVC (L) 2.36 ± 0.56 2.35 ± 0.5 2.38 ± 0.63 0.108
FEV1/FVC% 47.9 ± 10.7 48.9 ± 10.3 46.4 ± 11.1 0.751
6MWD 324.3 ± 57.7 340.7 ± 64 300.6 ± 33.8 <0.001
CAT 20.2 ± 7.7 19.6 ± 7.9 20.8 ± 7.3 0. 155
mMRC 2.4 ± 0.9 2.16 ± 0.9 2.69 ± 0.8 0.146
BDI 9.6 ± 5.4 8.3 ± 4.9 11.8 ± 5.4 0.021
SAI 38.5 ± 10.6 39.2 ± 10.4 38 ± 10.8 0.340
TAI 43.5 ± 10.7 43.8 ± 11 43.2 ± 10.6 0.363
Exacerbation 2.9 ± 1.6 2.7 ± 1.5 3.3 ± 1.7 0.004
Hospitalization 2.2 ± 1.4 2.3 ± 1.4 2.1 ± 1.6 0.374
Emergency visit 1.8 ± 0.9 1.7 ± 1.0 1.9 ± 1.2 0.280

Note. FVC: forced vital capacity (FVC) and FEV1: forced expiratory volume in 1 s. 6MWD: 6-minute walking distance; CAT, COPD assessment test; mMRC, modified Medical Research Council scale; BDI, Beck Depression Inventory; SAI, State Anxiety Inventory; and TAI, Trait Anxiety Inventory. For continuous variables, the results are expressed as mean ± standard deviation. A P value less than 0.05 is considered statistically significant and indicated by an asterisk ().